Latvian Biotech Startup PrintyMed Secures €2 Million in EU Grants for Spider-Silk Medical Device Development
In a EU‑Startups podcast, PrintyMed founder and CEO Jekaterina Romanova discussed the Latvian biotech startup’s biomimetic spider‑silk technology, its €2 million in EU grant funding, and plans to expand into Saudi Arabia while focusing on organ‑on‑a‑chip membranes for drug testing.